| Literature DB >> 1371898 |
H Joensuu1, K Kätkä, H Kujari.
Abstract
The combination of alpha-interferon and octreotide has rarely been tested in the treatment of carcinoid syndrome. We describe a patient who was moribund when treated with interferon alone, but enjoyed a dramatic response leading to disappearance of all symptoms, normalization of dU-5-HIAA, and restoration of his normal life-style when octreotide was initiated. Neither interferon nor octreotide could be withdrawn without reappearance of the symptoms, suggesting that the combination of alpha-interferon and octreotide may have synergistic effects in carcinoid syndrome.Entities:
Mesh:
Substances:
Year: 1992 PMID: 1371898 DOI: 10.1530/acta.0.1260184
Source DB: PubMed Journal: Acta Endocrinol (Copenh) ISSN: 0001-5598